Abstract: Ranitidine is a widely used drug and is known to be well tolerated. This case report illustrates a severe anaphylactic reaction after a single intravenous dose of 50 mgs of ranitidine and highlights this unusual but life threatening adverse reaction. The patient: A 56 year old female with acute pancreatitis and a known allergy to metronidazole and buscopan developed an anaphylaxis few minutes following the injection of ranitidine for epigastric discomfort. She went on to develop anaphylactic shock and a cardiorespiratory arrest. Management: She was managed with adrenaline, hydrocortisone and ventilatory support following which she had a full recovery. Conclusion: Awareness of this rare but life threatening adverse reaction to a co...
BECAUSE of the countless number of drugs in use these days, we can expect more and more reports of b...
Ranitidine is a H2 receptor blocker and rarely cause bradycardia. A 28 years old male patient attend...
The file attached to this record is the author's final peer reviewed version. The Publisher's final ...
Introduction: Ranitidine hydrochloride (Zantac®), a histamine-2-receptor antagonist, is a widely use...
Ranitidine is a histamine-2-receptor antagonist. It was a commonly used drug. It holds excellent saf...
ABSTRACT: INTRODUCTION: Ranitidine hydrochloride (Zantac(R)), a histamine-2-receptor antagonist, is ...
BACKGROUND: Histamine H2 receptor antagonists are commonly prescribed medications and are known to b...
Ranitidine is a very commonly used drug in clinical practice for acid peptic disease and has an exce...
Summary. Few reports exist on allergic reactions to ranitidine. We present a case of bronchospastic ...
Early clinical development of paclitaxel was complicated by life-threatening hypersensitivity reacti...
AbstractA 64-year-old woman was admitted to our emergency department with shortness of breath and pa...
Pramendra Prasad Gupta,1 Rabin Bhandari,1 Deebya Raj Mishra,2 Krishna Kumar Agrawal,3 Rupak Bhandari...
H 2 antagonist ranitidine causing thrombocytopenia is a rare drug phenomenon. Here we present a case...
Anaphylaxis is a serious life-threatening allergic reaction. Any medication may potentially trigger ...
Background: The emergent nature of anaphylaxis creates an environment of heightened risk for epineph...
BECAUSE of the countless number of drugs in use these days, we can expect more and more reports of b...
Ranitidine is a H2 receptor blocker and rarely cause bradycardia. A 28 years old male patient attend...
The file attached to this record is the author's final peer reviewed version. The Publisher's final ...
Introduction: Ranitidine hydrochloride (Zantac®), a histamine-2-receptor antagonist, is a widely use...
Ranitidine is a histamine-2-receptor antagonist. It was a commonly used drug. It holds excellent saf...
ABSTRACT: INTRODUCTION: Ranitidine hydrochloride (Zantac(R)), a histamine-2-receptor antagonist, is ...
BACKGROUND: Histamine H2 receptor antagonists are commonly prescribed medications and are known to b...
Ranitidine is a very commonly used drug in clinical practice for acid peptic disease and has an exce...
Summary. Few reports exist on allergic reactions to ranitidine. We present a case of bronchospastic ...
Early clinical development of paclitaxel was complicated by life-threatening hypersensitivity reacti...
AbstractA 64-year-old woman was admitted to our emergency department with shortness of breath and pa...
Pramendra Prasad Gupta,1 Rabin Bhandari,1 Deebya Raj Mishra,2 Krishna Kumar Agrawal,3 Rupak Bhandari...
H 2 antagonist ranitidine causing thrombocytopenia is a rare drug phenomenon. Here we present a case...
Anaphylaxis is a serious life-threatening allergic reaction. Any medication may potentially trigger ...
Background: The emergent nature of anaphylaxis creates an environment of heightened risk for epineph...
BECAUSE of the countless number of drugs in use these days, we can expect more and more reports of b...
Ranitidine is a H2 receptor blocker and rarely cause bradycardia. A 28 years old male patient attend...
The file attached to this record is the author's final peer reviewed version. The Publisher's final ...